PheroidTM-based anti-malarial formulations : HPLC method development and stability studies
Malaria remains one on the world's most common infectious diseases with 300 to 500 million cases every year. The current treatment of malaria is restricted due to ever increasing drug resistance, cost of treatment and the availability of treatment. When looking at solutions for these problems,...
| Main Author: | |
|---|---|
| Language: | en |
| Published: |
North-West University
2011
|
| Online Access: | http://hdl.handle.net/10394/4180 |